Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FPHAX vs ETHSX overlap: 38% of top holdings shared

Bottom line

How much do FPHAX and ETHSX overlap?

38% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 52.7% of FPHAX's assets and 40.6% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

FPHAXETHSX
Weight overlap (top 25)38%
Shared holdings7
Weight in shared holdings52.7%40.6%
Total positions5742
Expense ratio0.67%1.18%
Holdings as ofMay 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Holdings FPHAX and ETHSX have in common

Holding% of FPHAX% of ETHSXOverlap
ELI LILLY and CO28.78%12.47%12.47%
MERCK and CO INC4.74%5.08%4.74%
Roche Holding Ag4.54%5.44%4.54%
Astrazeneca Plc4.22%6.24%4.22%
Gilead Sciences Inc3.97%3.34%3.34%
JOHNSON and JOHNSON3.77%6.45%3.77%
Royalty Pharma Plc2.67%1.58%1.58%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FPHAX

  1. Gsk Plc — 8.17%
  2. Viatris Inc — 5.45%
  3. Ucb Sa — 5.09%
  4. Legend Biotech Corp — 4.53%
  5. Elanco Animal Health Inc — 4.15%
  6. Jazz Pharmaceuticals Plc — 4.09%
  7. Fidelity Revere Street Trust — 2.44%
  8. Moderna Inc — 1.57%
  9. Intellia Therapeutics Inc — 1.19%
  10. Beam Therapeutics Inc — 1.10%
  11. Axsome Therapeutics Inc — 1.08%
  12. Biontech Se — 1.04%
  13. Xenon Pharmaceuticals Inc — 0.82%
  14. Ocular Therapeutix Inc — 0.80%
  15. Idexx Laboratories Inc — 0.61%

Only in ETHSX

  1. AbbVie Inc — 6.46%
  2. UnitedHealth Group Inc — 5.49%
  3. Bristol-Myers Squibb Co — 4.25%
  4. Vertex Pharmaceuticals Inc — 3.38%
  5. Sanofi SA — 2.95%
  6. Thermo Fisher Scientific Inc — 2.79%
  7. Intuitive Surgical Inc — 2.72%
  8. Stryker Corp — 2.21%
  9. Boston Scientific Corp — 2.18%
  10. Medtronic PLC — 1.80%
  11. Lonza Group AG — 1.77%
  12. Novo Nordisk A/S — 1.71%
  13. Abbott Laboratories — 1.65%
  14. Novartis AG — 1.65%
  15. Argenx SE — 1.61%

Asset mix

Asset typeFPHAXETHSX
Stocks98.7%99.4%
Cash & short-term funds2.6%0.3%
Preferred stock0.7%—
Bonds0.1%—

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Country mix

CountryFPHAXETHSX
US64.8%69.4%
GB15.1%7.8%
CH4.5%10.2%
BE5.3%—
KY4.5%—
IE4.1%1.8%
FR—3.2%
DK0.3%2.9%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do FPHAX and ETHSX overlap?
About 38% by weight. 7 securities appear in both funds' top 25 holdings; they make up 52.7% of FPHAX's assets and 40.6% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FPHAX and ETHSX have in common?
The largest shared holdings are ELI LILLY and CO, MERCK and CO INC, Roche Holding Ag, Astrazeneca Plc, JOHNSON and JOHNSON.
Should I own both FPHAX and ETHSX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FPHAX or ETHSX?
FPHAX is broader, with 57 positions versus 42 for ETHSX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.